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http://dx.doi.org/10.1016/j.kjms.201Abstract Acute kidney injury (AKI) is a potential complication following cardiopulmonary
bypass (CPB) surgery in infants and young children with congenital heart disease (CHD). The
current pilot study evaluates the predictive value of serum cystatin C (CysC) for AKI after pe-
diatric CPB surgery. We prospectively enrolled 43 children with CHD (30 males and 13 females)
who underwent CPB surgery. They were aged 3 years or younger. Serum CysC was measured at
baseline and at 6 hours, 12 hours, 24 hours, and 48 hours after initiating CBP. Twenty-one
(48.8%) patients developed AKI after cardiac surgery. Children who developed AKI had more
complex cardiac surgical procedures (based on the Risk Adjustment for Congenital Heart Sur-
gery 1 [RACHS-1] category), a longer CPB duration, and a longer aortic clamping time (ACT).
Serum concentrations of CysC postoperatively demonstrated an initial decline at 6 hours, a sub-
sequent increase at 12 hours, and stabilized at 24e48 hours. The best predictive performance
was achieved 6 hours after CPB with an area under receiver operating characteristic curve
(AUC) value of 0.69. The optimal cut-off value was 0.47 mg/L (sensitivity, 85.7%; specificity,
50%). By contrast, the RACHS-1 category, CPB duration, and ACT had higher AUC values at
0.735, 0.791, and 0.731, respectively. In conclusion, serum CysC had limited predictive capac-
ity and was not superior to clinical risk factors for the early detection of AKI after CPB surgery
in this pilot study, which focused on infants and young children.
Copyright ª 2013, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights
reserved.t of Pediatric Cardiology and Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University,
ple’s Republic of China.
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were congenital abnormality of the urological system, se-In children with congenital heart disease (CHD), renal
injury is a potential complication following cardiopulmo-
nary bypass (CPB) surgery [1,2]. The spectrum ranges from
subclinical injury to acute renal failure (ARF) that requires
peritoneal dialysis (PD). Despite substantial improvements
in surgical techniques and perioperative management,
ARF-associated morbidity and mortality remain high. Ac-
cording to a recent summary, ARF affects 1.6e32.8% of
pediatric patients and has mortality rates of 20e79% [3].
The Acute Kidney Injury Network (AKIN) recently sup-
ported the use of the term “acute kidney injury” (AKI) to
denote the entire spectrum of acute renal injuries,
including ARF [4].
The current AKI diagnostic criteria are based on changes
in the serum creatinine level and clinical oliguria [4].
However, the serum creatinine level is not an early indi-
cator during acute changes in renal function. Its concen-
tration fails to increase until 50% of kidney function has
already been lost [5], and it does not accurately depict
renal function until a steady state equilibrium has been
reached, which can take several days after the initial
insult. Therefore, the elevation of serum creatinine lags
behind renal injury and decline of renal function. The AKIN
adopted a 48-hour window for a creatinine-based defi-
nition. Previous studies have shown that AKI and ARF can be
prevented and/or treated by several maneuvers such as
renal replacement therapy, but these maneuvers must be
instituted very early after the initial insult and well before
the serum creatinine level begins to rise [6]. The diagnosis
unfortunately is often delayed; therefore, the quest for
improving the early diagnosis of AKI is an area of intense
research.
Cystatin C (CysC) is a cysteine protease inhibitor that is
synthesized and released into the blood at a relatively
constant rate by all nucleated cells. It is freely filtered by
the glomerulus, completely reabsorbed and metabolized by
the proximal tubules, and is not secreted. These inherent
properties make serum CysC an attractive and promising
biomarker for assessing renal glomerular function, com-
pared to serum creatinine. Measuring the serum CysC level
may provide new insight into the early diagnosis of AKI.
Recent studies show that in many clinical settings serum
CysC has diagnostic value when measured early (e.g.,
within 24 hours after the renal insult or after intensive care
unit admission) [7,8]. It is also superior to conventional
biomarkers in predicting AKI soon after adult cardiac sur-
gery [9]. However, the performance of serum CysC as
a biomarker has been less frequently studied in infants and
young children in whom the risk of postoperative ARF is
high. The aim of this pilot study was to investigate the
predictive value of serum CysC for AKI after CPB surgery in
the very young population.
Design and methods
Study population
During a 6-month period, we prospectively enrolled all
children with CHD, aged 3 years or less, who underwent CPBsurgery at Beijing Anzhen Hospital. The exclusion criteria
vere liver dysfunction, primary blood disease, malignant
tumor, and use of nephrotoxic drugs before admission and
during the study period. Based on whether AKI developed
after surgery, the subjects were divided into the AKI group
and non-AKI group. According to the AKIN criteria and other
studies that involved children, AKI was defined as an acute
decline in renal function within 72 hours of surgery; an
absolute increase in serum creatinine level of 0.3 mg/dL
(26.4 mmol/L) or greater; a 50% or greater percent increase
in serum creatinine; or reduced urine output of less than
0.5 mL/kg per hour for more than 6 hours [4]. Because of
the possibility of hemodilution associated with CPB and the
delayed increase in the serum creatinine level needed to
achieve the AKIN criteria, we adopted a 72-hour period,
which has often been used in other pediatric studies,
instead of 48 hours.Sample collection and measurement of serum CysC
We collected blood samples at baseline, and at 6 hours, 12
hours, 24 hours and 48 hours after initiating CBP. The
samples were centrifuged at 2000  g for 10 minutes and
the serum supernatants were stored at e80C. By using
a commercially available kit for human CysC (N latex CysC
Kit; Dade Behring, Marburg, Germany) and BN II system
(Siemens Healthcare Diagnostics, Deerfield, IL), the serum
CysC concentrations were measured at the clinical labora-
tory of Peking University First Hospital by a particle-
enhanced nephelometric immunoassay. The lower limit of
detection for CysC was 0.05 mg/L. The intra-assay and
interassay coefficients of variation were below 2.5% and 5%,
respectively. The serum creatinine level was measured
routinely at baseline and twice daily during the first three
postoperative days and once daily thereafter. The parents
or legal guardian of each child provided written, informed
consent.Statistical analysis
Statistics analysis was performed by using SPSS version
13.0 (SPSS, Chicago, IL). Normally distributed variables
were expressed as the mean  SD, whereas non-normally
distributed variables were expressed as the median (i.e.,
interquartile range). Continuous variables were com-
pared by using the two independent samples t test or the
rank sum test. Categorical variables were displayed as
a percentage and compared by using the c2 test or Fisher
exact test. The receiver operating characteristic (ROC)
curve was generated. The area under the ROC curve
(AUC) was measured to evaluate the predictive perfor-
mance of the serum CysC level for AKI. An AUC value of
1.0 signified a perfect biomarker, and a value of 0.5 sig-
nified it was no better than what would be expected by
chance. The optimal cut-off value was the value that had
the highest combined sensitivity and specificity. A two-
sided p value of < 0.05 was considered statistically
significant.
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Clinical information
Sixty children were initially considered for participation in
the study, and 43 children (30 males and 13 females) met
the inclusion criteria and constituted the study cohort.
Table 1 summarizes the patients’ clinical characteristics
and outcomes. Twenty-one (48.8%) patients developed AKI
after cardiac surgery. No significant differences existed
with respect to gender, age, and weight between the two
groups. Compared to children who did not develop AKI,
children who developed AKI had more complex cardiac
surgical procedures (based on the Risk Adjustment for
Congenital Heart Surgery 1 [RACHS-1] category) (Table 2),
longer CPB and aortic clamping times (ACT), and worse
clinical outcomes. Urine output during the first 24 hours
after surgery did not differ between the two groups. In the
AKI group, one child developed ARF requiring PD and two
patients died. The hospital stay in the intensive care unit
(ICU) was longer in the AKI group than in the non-AKI group.
Serial measurements of serum CysC
Table 3 shows the measurements of the serum CysC level at
baseline and at the various timepoints after CPB surgery.
The baseline concentrations were comparable between the
two groups. In both groups, the serum CysC concentrations
showed an initial decline at 6 hours, but had increased by
12 hours, and stabilized at 24e48 hours postoperatively. In
the AKI group, the serum CysC concentration approached
baseline levels 24e48 hours after surgery. By contrast, the
serum CysC concentration in the non-AKI group remained
lower at 48 hours than at baseline.
ROC analysis of serum CysC for predicting AKI
Table 3 and Fig. 1 illustrate the ROC analysis of serum CysC
for predicting AKI. The best predictive performance wasTable 1 Patients’ clinical characteristics and outcomes.
Items Non
Males, n (%)
Age (mo)
Weight (kg)
RACHS-1
CPB (min) 1
ACT (min)
Serum creatinine baseline (mmol/L)
Serum creatinine 24 h (mmol/L)
Serum creatinine 48 h (mmol/L)
Serum creatinine 72 h (mmol/L)
Serum creatinine 96 h (mmol/L)
Urine output during the first 24 h (mL/kg per h)
ICU hospital stay (days)
ARF requiring PD, n (%)
Death, n (%)
ACT Z aortic clamping time; AKI Z acute kidney injury; ARF Z
ICU Z intensive care unit; PD Z peritoneal dialysis; RACHS-1 Z Riskachieved 6 hours after CPB with an AUC value of 0.69. The
optimal cut-off value at 6 hours was 0.47 mg/L (sensitivity,
85.7%; specificity, 50%; positive predictive value, 62.1%;
and negative predictive value, 78.6%). By contrast, RACHS-
1 category, CPB duration, and ACT had higher AUC values of
0.735, 0.791, and 0.731, respectively.Discussion
The incidence of AKI in infants and young children after
congenital heart surgery was high in this pilot study. Clini-
cal risk factors included a high RACHS-1 category, pro-
longed CPB time, and prolonged ACT. The consensus-based
algorithm, RACHS-1, is based on in-hospital mortality of
children after congenital heart surgery; higher RACHS-1
categories portend a higher mortality [10]. In this small
cohort, all children were assigned to categories 2 to 4.
Category 1 included simple cardiac defects (such as iso-
lated atrial septal defect) and partially anomalous pulmo-
nary venous connection. Patients in this category rarely
underwent CPB surgery at a very young age. Cardiac sur-
gical procedures in categories 5 and 6 were highly complex
and rarely performed in our center. No category 5 or 6
patients were admitted during the study period.
In recent years, the early diagnosis of AKI by using
kidney-specific biomarkers has become a field of intensive
study and could facilitate early intervention in high-risk
individuals. Serum CysC is a theoretically ideal and prom-
ising index of glomerular function, compared to serum
creatinine. A prominent advantage of measuring serum
creatinine is that a standardized immunonephelometric
assay is available that is automated and provides results in
minutes. In addition, routine clinical storage conditions,
freeze/thaw cycles, and the presence of interfering sub-
stances do not seem to affect its measurement. Serum CysC
is currently being investigated and validated for its ability
to predict AKI under different clinical circumstances. In
critical care settings, serum CysC predicted AKI 1 to 2 days
earlier than serum creatinine [8]. Preoperative serum CysC-AKI (n Z 22) AKI (n Z 21) p
15 (68.2) 15 (71.4) 0.817
13.9  12.6 11.1  12.4 0.479
7.7  2.4 6.9  3.2 0.358
2.4  0.6 3.1  0.8 0.003
04.1  42.3 160.9  62.5 0.001
64.2  31.3 98.9  49.8 0.009
32.0  15.1 36.8  10.1 0.229
29.8  10.2 41.7  15.9 0.008
30.3  15.8 58.9  19.6 <0.001
29.6  11.4 60.8  22.6 <0.001
31.4  10.3 61.6  31.4 <0.001
3.6  1.5 4.1  1.4 0.301
4.8  4.0 6.7  2.5 0.086
0 1 (4.8) d
0 2 (9.5) d
acute renal failure; CPB Z cardiopulmonary bypass duration;
Adjustment for Congenital Heart Surgery 1.
Table 2 Cardiac surgical procedures categorized by RACHS-1.
Category and surgery Non-AKI (n Z 22) AKI (n Z 21)
Category 2
Repair of aorta-pulmonary window 1 0
Repair of TAPVC at age >30 d 2 2
Total repair of TOF 7 2
Ventricular septal defect repair 2 0
ASD and VSD repair 2 1
Pulmonary valvotomy or valvuloplasty 1 1
Category 3
Arterial switch operation 0 1
Repair of complete AVSD 1 3
Repair of complete AVSD and TAPVC with pulmonary artery band removal 0 1
Repair of coarctation and VSD closure 3 2
Repair of DORV with or without repair of right ventricular obstruction 2 0
Repair of TOF with pulmonary atresia 0 1
Category 4
Arterial switch operation with VSD closure 1 4
ASO with pulmonary artery band removal 0 1
Repair of TAPVC at age 30 d 0 1
Double switch 0 1
ASD Z atrial septal defect; ASO Z arterial switching operation; AVSD Z atrioventricular septal defect; DORV Z double-outlet right
ventricle; RACHS-1 Z Risk Adjustment for Congenital Heart Surgery 1; TAPVC Z total anomalous pulmonary venous connection;
TOF Z tetralogy of Fallot; VSD Z ventricular septal defect.
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following cardiac surgery, compared to serum creatinine
[11,12].
In this pilot study, serum CysC concentrations demon-
strated an initial decline after CPB and remained lower
than the baseline levels up to 48 hours after surgery in
many patients. This may be attributed to hemodilution
associated with CPB. This effect could be more prominent
in infants and young children because of their lower body
weight and blood volume. In ROC analysis, serum CysC
showed a limited ability to predict AKI after pediatric heart
surgery. Its predictive values (AUC, 0.56e0.69) were much
lower than the predictive values of clinical risk factors such
as the RACHS-1 category, CPB duration, and ACT. This
finding was consistent with the results of recent studies on
adult CPB surgery [13e15]. In a study conducted by Wald
et al. [14], the plasma CysC concentration also demon-
strated an initial decline after CPB and was higher at all
timepoints in patients who developed AKI than in patients
who did not develop AKI. The discriminatory capacity ofTable 3 Measurement of serum Cystatin C and ROC analysis fo
Time Non-AKI (mg/L) n Z 22 AKI (mg/
Baseline 0.78  0.32 0.76
PO 6 h 0.53  0.15 0.66
PO 12 h 0.63  0.18 0.69
PO 24 h 0.63  0.16 0.75
PO 48 h 0.62  0.18 0.74
AKIZ acute kidney injury; AUCZ area under ROC curve; POZ postop
deviation.plasma CysC measured preoperatively (AUC, 0.57) and at
2 hours after the conclusion of CPB (AUC, 0.61) was modest
[14]. Koyner et al. [15] also suggested plasma CysC, with an
AUC value of 0.62 at 2 hours postoperatively, was not an
early predictor of AKI after adult cardiac surgery. In elderly
patients undergoing cardiac surgery, serum CysC was not
superior to plasma creatinine for the early detection of
postoperative AKI [13]. In these studies, the initial decline
of the serum CysC concentration seemed to limit its ca-
pacity for AKI prediction soon after cardiac surgery. The
pathogenesis of CPB-related AKI was renal tubular injury,
which is mediated by ischemiaereperfusion injury, inflam-
matory reaction, and microembolism [16]. However, serum
CysC is a well-known index of glomerular function. The
delay from tubular injury to subsequent glomerular dys-
function may explain the limited performance of serum
CysC as an early predictor of AKI.
However, several other studies suggest that serum CysC
could serve as an early predictive biomarker for AKI after
pediatric and adult CPB surgery [9,17]. In patients whor AKI prediction.
L) n Z 21 p AUC (95% CI)
 0.30 0.855 0.518 (0.341e0.696)
 0.24 0.036 0.690 (0.529e0.852)
 0.23 0.325 0.564 (0.390e0.738)
 0.35 0.172 0.603 (0.422e0.783)
 0.31 0.135 0.609 (0.428e0.790)
erative; ROCZ receiver operating characteristic; SDZ standard
Figure 1. The receiver operating characteristic analysis of
serum cystatin C for the prediction of AKI at 6 h after CPB.
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increased substantially within the first 12 hours following
CPB; the CysC level had good predictive values at 12e24 h
(AUC, 0.81e0.91) [9,17].
The reason for the divergent results among the studies is
unclear. The discrepancy in the postoperative changing
patterns of serum CysC may be related to different strat-
egies used among the centers in fluid management in the
operating room. However, these data are rarely reported in
the literature. Future studies are required that evaluate
the effect of CPB fluid management on the predictive ca-
pacity of serum CysC.
The serum concentration of CysC is not significantly
influenced by nonrenal factors that affect the serum cre-
atinine concentration. However, cardiac function is clearly
associated with renal dysfunction and thus serum CysC
levels. Cardiac injury and dysfunction are other well-
recognized potential complications associated with CPB
surgery. Aside from direct renal injury from CPB insult,
impaired cardiac function and low cardiac output could
cause persistent renal hypoperfusion and further aggravate
renal injury after surgery. Postoperative fluid management
may also play an important role in AKI and its clinical out-
come. Adequate hydration and the use of inotropic and
diuretic agents to avoid volume depletion and support
cardiac function could maintain effective renal perfusion
and prevent the further progression of AKI [18]. Thus, the
state of postoperative cardiac function and perioperative
management could affect postoperative serum CysC con-
centrations and should be considered when trying to
explain the discrepancy among studies.
The major limitation of our study is the small sample
volume. Only one child (4.8%) developed ARF and required
PD. The predictive capacity of serum CysC for ARF cannot
be inferred from the preliminary results of this pilot study
and must be further determined in future large-scale
studies.In summary, in this pilot study, the serum CysC con-
centration had limited predictive capacity and was not
superior to clinical risk factors for the early detection of AKI
after CPB surgery in infants and in young children.
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